These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31989658)

  • 1. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
    Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
    Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.
    Guan Y; Bhandari A; Xia E; Kong L; Zhang X; Wang O
    Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):116-124. PubMed ID: 31942970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
    Lin BY; Wen JL; Zheng C; Lin LZ; Chen CZ; Qu JM
    J Cell Mol Med; 2020 Nov; 24(22):13070-13080. PubMed ID: 32969138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.
    Zhou Y; Xiang J; Bhandari A; Wen J; Lin B; Kong L; Wang O
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):696-702. PubMed ID: 31855284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wen J; Lin B; Lin L; Chen Y; Wang O
    Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
    Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
    Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.
    Zheng C; Quan R; Xia EJ; Bhandari A; Zhang X
    Oncol Lett; 2019 Sep; 18(3):3227-3235. PubMed ID: 31452800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Lee HJ; Hah YS; Cheon SY; Won SJ; Yim CD; Ryu S; Lee SJ; Seo JH; Park JJ
    Eur Thyroid J; 2024 Oct; 13(5):. PubMed ID: 39121020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhou X; Lin L; Qi Y; Xu M; Xu Q; Wang Y; Qu J
    Dis Markers; 2022; 2022():2562595. PubMed ID: 35968508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.
    Wen X; Wang N; Zhang F; Dong C
    Mol Med Rep; 2016 Mar; 13(3):2885-91. PubMed ID: 26847210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
    Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
    Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z; Liu Y; Ma M; Chang L
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jiang W; Quan R; Bhandari A; Hirachan S; Chen C; Lv S; Zheng C
    Curr Med Chem; 2024; 31(9):1152-1164. PubMed ID: 37102492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.